GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) or under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
Talking with your doctor is so important
An open dialogue with your doctor means your questions are getting answered, whether you’re just starting therapy or have been on therapy for a while. Your doctor or nurse should know if you have any concerns or any side effects that are bothering you.
They’ll be able to talk to you about what this could mean for you.
We get that. You may talk to your doctor about going from monthly to weekly infusions, or vice versa. There are other Takeda therapies to treat PI that you’ll want to know about if you ever decide to make a change.
GAMMAGARD LIQUID is one of three Takeda therapies to treat PI. Whatever therapy changes you may need, Takeda is here for you. The chart below highlights key details about GAMMAGARD LIQUID (in orange) and the other two medicines to treat PI.
GAMMAGARD LIQUID IV | SubQ IG with flexible infusion options | Once-a-month* SubQ IG infusion | |
---|---|---|---|
Administration options | In a vein | Under the skin | Under the skin with hyaluronidase that helps more IG to be absorbed into the bloodstream |
Frequency | Every 3 to 4 weeks | Daily to every 2 weeks | Every 3 to 4 weeks |
Average infusion time† | ~2 hours | ~1 to 2 hours | ~2 hours |
Infusion time range† | ~1 to 2 hours | ~5 min to 2 hours | ~1 to 2 hours |
Who administers | Nurse | Yourself or care partner after training by HCP | Nurse or yourself or care partner after training by HCP |
Location | Home, healthcare office, hospital, or infusion center | Home, healthcare office, hospital, or infusion center | Home, healthcare office, hospital, or infusion center |
Learn more | Learn more |
*Every 3 or 4 weeks.
†Infusion times may vary based on frequency, dose, volume, number of needlesticks, and tolerability.
*Every 3 or 4 weeks.
IMPORTANT SAFETY INFORMATION and serious warnings regarding blood clots, decreased kidney function or kidney failure
What is the most important information that I should know about GAMMAGARD LIQUID?
GAMMAGARD LIQUID can cause the following serious reactions: severe allergic reactions causing difficulty in breathing or skin rashes; decreased kidney function or kidney failure; blood clots in the heart, brain, lungs or elsewhere in the body; severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting; dark colored urine, swelling, fatigue, or difficulty breathing.
INDICATION
What is GAMMAGARD LIQUID?
GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) or under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
Important Safety Information
What is the most important information that I should know about GAMMAGARD LIQUID?
GAMMAGARD LIQUID can cause the following serious reactions:
Who should not use GAMMAGARD LIQUID?
Do not use GAMMAGARD LIQUID if you:
What should I avoid while taking GAMMAGARD LIQUID?
What are the possible or reasonably likely side effects of GAMMAGARD LIQUID?
GAMMAGARD LIQUID can cause serious side effects. If any of the following problems occur after starting GAMMAGARD LIQUID, stop the infusion immediately and contact your HCP or call emergency services:
The following one or more possible reactions may occur at the site of infusion of GAMMAGARD LIQUID for PI, generally go away within a few hours, and are less likely after the first few infusions:
During the infusion of GAMMAGARD LIQUID for PI, look out for the first signs of the following common side effects:
These are not all the possible side effects. Talk to your HCP about any side effect that bothers you or that does not go away.
For additional safety information including Warning about Blood Clots, Decreased Kidney Function, and Kidney Failure, click for Information for Patients and discuss with your HCP.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.